TrialPloS one2011

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).

Gavin J Churchyard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.